Epiberberine ameliorates MNNG-induced chronic atrophic gastritis by acting on the EGFR-IL33 axis
International Immunopharmacology · 2025-01 · 145 · 113718
DOI: 10.1016/j.intimp.2024.113718 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-01. Verfasst von Juan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Coptis Development and Utilization (Ministry of Education), School of Life Sciences, Southwest University, Chongqing 4…. Hauptthemen laut MEDLINE: ErbB Receptors, Gastritis, Atrophic, Gastric Mucosa, Interleukin-33. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Chronic atrophic gastritis (CAG) is a prevalent form of chronic gastritis that presents with chronic inflammation of the gastric mucosa, localised gastric mucosal glandular atrophy and intestinal metaplasia. Despite the existence of diagnostic criteria, effective therapeutic strategies for this condition remain to be developed. The objective of this study was to examine the potential therapeutic benefits of epiberberine in mitigating MNNG-induced CAG and to elucidate the underlying mechanisms. MNNG was employed to establish a CAG mouse model and a GES-1 cell model, and EPI was observed to be efficacious in ameliorating the gastric mucosal injury and inflammatory infiltration induced by MNNG in the CAG model mice, a finding that was subsequently validated in the GES-1 model cells. Bioinformatics analysis indicated that EPI may exert a direct effect on EGFR, thereby regulating the expression of IL-33 and thereby achieving the therapeutic effect of CAG. This hypothesis was also validated by molecular docking prediction, CETSA, and overexpression of EGFR in GES-1 model cells, using EGFR agonists and inhibitors to further demonstrate that EPI may act as an antagonist supplement to EGFR for the treatment of CAG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Research Center of Coptis Development and Utilization (Ministry of Education), School of Life Sciences, Southwest University, Chongqing 400715, China; College of Pharmaceutical Sciences, Southwest University…
- Engineering Research Center of Coptis Development and Utilization (Ministry of Education), School of Life Sciences, Southwest University, Chongqing 400715, China.
- College of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China. Electronic address: xuegangli@swu.edu.cn.
- Department of Gastroenterology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400000, China. Electronic address: cwq20130219@163.com.
- College of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China. Electronic address: hangma@swu.edu.cn.
- Engineering Research Center of Coptis Development and Utilization (Ministry of Education), School of Life Sciences, Southwest University, Chongqing 400715, China. Electronic address: yexiaoli@swu.edu.cn.
Zitieren
APA
Li, J., Chen, X., Mao, C., Xiong, M., Ma, Z., Zhu, J., Li, X., Chen, W., Ma, H., & Ye, X. (2025). Epiberberine ameliorates MNNG-induced chronic atrophic gastritis by acting on the EGFR-IL33 axis. International Immunopharmacology, 145, 113718. https://doi.org/10.1016/j.intimp.2024.113718
Vancouver
Li J, Chen X, Mao C, Xiong M, Ma Z, Zhu J, et al. Epiberberine ameliorates MNNG-induced chronic atrophic gastritis by acting on the EGFR-IL33 axis. International Immunopharmacology. 2025;145:113718. doi:10.1016/j.intimp.2024.113718
BibTeX
@article{Li2025,
author = {Li, Juan and Chen, Xiantao and Mao, Changxia and Xiong, Mengyuan and Ma, Zhengcai and Zhu, Jianyu and Li, Xuegang and Chen, Wanqun and Ma, Hang and Ye, Xiaoli},
title = {Epiberberine ameliorates MNNG-induced chronic atrophic gastritis by acting on the EGFR-IL33 axis},
journal = {International Immunopharmacology},
year = {2025},
volume = {145},
pages = {113718},
doi = {10.1016/j.intimp.2024.113718}
}
EUVIMED